NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.
Reference is made to the stock exchange announcement published by SoftOx Solution AS (the “Company”) on September 17th and 18th, 2024, regarding increasing the share capital by converting outstanding claims to new shares in the Company.
…
Vis børsmeldingen
The following primary insiders and close associates to primary insiders have been allocated new shares:
Hermod Farms AS, a company owned by Geir Almås, has been allocated 58 326 042 shares in the Company. As a result, Geir Almås together with his fully owned company Hermod Farms AS holds 108 227 891 shares in the Company.
Christian Harstad has been allocated 9 900 000 shares in the Company. As a result, Christian Harstad holds 9 900 000 shares in the company.
For any questions please contact:
Ingrid Juven, CFO SoftOx Solutions AS
Mail: ir@soft-ox.com
Phone: Ingrid Juven: (+47) 918 76 165
About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx) is a Medtech, and pharmaceutical company listed on Euronext Growth Oslo under ‘SOFTX’. SoftOx Solutions AS was founded in 2012 and is headquartered in Oslo. The SoftOx Solutions Group includes the holding company SoftOx Solutions AS, the Malmö subsidiary Water Innovation AB, and subsidiaries SoftOx Defense Solutions AS and SoftOx Disinfection AS. SoftOx is developing a highly effective antimicrobial solution for biofilm, viral, and antimicrobial-resistant infections. The patent-protected technology is based on extensive research and development in partnership with leading Nordic research institutes.
For more information on SoftOx, visit www.soft-ox.com
Kilde
